NCT05961137

Brief Summary

The goal of this quality improvement study is to measure the impact of incorporation of a manual rapid fluid infuser (RFI) for intravenous crystalloid infusion in patients with suspected sepsis in the prehospital interval. The main question\[s\] it aims to answer are:

  • Does the intervention affect the timeliness of fluid administration?
  • Does the intervention affect CMS sepsis bundle care measure compliance?
  • Does the intervention affect processes and outcomes of care?
  • Are there any adverse effects? Researchers will compare this intervention to use of more conventional gravity or pressure-infusion bag crystalloid infusion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P25-P50 for not_applicable sepsis

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2022

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

May 22, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 27, 2023

Completed
Last Updated

July 27, 2023

Status Verified

July 1, 2023

Enrollment Period

9 months

First QC Date

May 22, 2023

Last Update Submit

July 17, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Percentage compliance with the CMS 3-hour sepsis bundle criterion (SEP-1) for patients with suspected sepsis

    As defined according to the Centers for Medicare and Medicaid Services (CMS) Specifications Manual for Hospital Inpatient Quality Measures, version 5.9. "Time of presentation" or "time-zero" was defined as the time of triage in the Emergency Department. All patients enrolled in the study were assessed for measure compliance, without application of measure inclusion/exclusion criteria.

    Assessed at 3 hours after ED arrival

Secondary Outcomes (13)

  • Percentage achievement of 30mL/kg crystalloid infusion for hypotension or lactate level > 4 mmol/L at 1 hour

    Assessed at 1 hour after ED arrival

  • Total volume of intravenous crystalloid infused by time of ED arrival

    During the 3 hours prior to ED arrival, while under care by EMS.

  • Total volume of intravenous crystalloid infused by 1 hour after ED arrival

    Assessed at 1 hour after ED arrival

  • Total volume of intravenous crystalloid infused by 3 hours after ED arrival

    Assessed at 3 hours after ED arrival

  • Total volume of intravenous crystalloid infused, in the ED, by 1 hour after ED arrival

    Assessed at 1 hour after ED arrival

  • +8 more secondary outcomes

Study Arms (2)

After-phase: Incorporation of Rapid Fluid Infusion Device in Prehospital Suspected Sepsis Protocol

ACTIVE COMPARATOR

Modified protocol specifying intravenous crystalloid infusion Rapid Fluid Infusion Device. The protocol states that for patients meeting the sepsis alert criterion, EMS will provide basic medical care, oxygen, a 12-lead electrocardiogram, attempt placement of an IV catheter and initiate administration of 30mL/kg of fluids.

Other: Incorporation of Rapid Fluid Infusion Device in Prehospital Suspected Sepsis Protocol

Before phase: Conventional Prehospital Suspected Sepsis Protocol

ACTIVE COMPARATOR

Conventional protocol employing intravenous crystalloid infusion via gravity or pressurized-bag. The protocol states that for patients meeting the sepsis alert criterion, EMS will provide basic medical care, oxygen, a 12-lead electrocardiogram, attempt placement of an IV catheter and initiate administration of 30mL/kg of fluids.

Other: Conventional Prehospital Suspected Sepsis Protocol

Interventions

Modified protocol specifying intravenous crystalloid infusion Rapid Fluid Infusion Device. The protocol states that for patients meeting the sepsis alert criterion, EMS will provide basic medical care, oxygen, a 12-lead electrocardiogram, attempt placement of an IV catheter and initiate administration of 30mL/kg of fluids.

After-phase: Incorporation of Rapid Fluid Infusion Device in Prehospital Suspected Sepsis Protocol

Conventional protocol employing intravenous crystalloid infusion via gravity or pressurized-bag. The protocol states that for patients meeting the sepsis alert criterion, EMS will provide basic medical care, oxygen, a 12-lead electrocardiogram, attempt placement of an IV catheter and initiate administration of 30mL/kg of fluids.

Before phase: Conventional Prehospital Suspected Sepsis Protocol

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients meeting sepsis alert criteria who were transported to the study hospital's emergency department by one of the four rescue units involved in the study. Sepsis alert defined as patient has suspected infection and two or more of the following: (a) temperature \> 38° C (100.4° F) or \< 36° C (96.8° F), (b) respiratory rate \> 20 breaths / minute or end-tidal carbon dioxide (ETCO2) ≤ 25 mmHg, or (c) heart rate \> 90 beats / minute

You may not qualify if:

  • prehospital trauma
  • prehospital cardiac arrest prior to signaling sepsis alert
  • interfacility transfer
  • emergency transport from medical facility (e.g., medical office or clinic)
  • intervention by medical practitioner before emergency medical services arrival
  • do not resuscitate order in place

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Orange Park Medical Center

Orange Park, Florida, 32073, United States

Location

MeSH Terms

Conditions

SepsisShock, Septic

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShock

Study Officials

  • Martin P Wegman, MD, PhD

    Orange Park Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Two-group design with control group enrolled first, then a training period, then a separate intervention group enrolled.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 22, 2023

First Posted

July 27, 2023

Study Start

April 1, 2021

Primary Completion

December 31, 2021

Study Completion

August 31, 2022

Last Updated

July 27, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations